Bath & Body Works, Inc. (BBWI) stock
Close on Nov 11, 2026Market cap $4.38BP/E 5.7Yield 3.68%
Earnings
Bath & Body Works's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Bath & Body Works's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Nov 1, 2026 | Nov 19, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Aug 1, 2026 | Aug 26, 2026before the open | $1.51B | -2.3% | $0.58 | $0.62 | Release |
| Q1 FY2026ended May 2, 2026 | May 27, 2026before the open | $1.38B | -3.2% | $0.90 | $0.32 | Release |
| Q4 FY2025ended Jan 31, 2026 | Mar 4, 2026before the open | $2.72B | -2.3% | $1.99 | $2.05 | Release |
| Q3 FY2025ended Nov 1, 2025 | Nov 20, 2025before the open | $1.59B | -1.0% | $0.37 | $0.35 | Release |
| Q2 FY2025ended Aug 2, 2025 | Aug 28, 2025before the open | $1.55B | +1.5% | $0.30 | $0.37 | Release |
| Q1 FY2025ended May 3, 2025 | May 29, 2025before the open | $1.42B | +2.9% | $0.49 | – | Release |
| Q4 FY2024ended Feb 1, 2025 | Feb 27, 2025before the open | $2.79B | -4.3% | $2.09 | $2.09 | Release |
| Q3 FY2024ended Nov 2, 2024 | Nov 25, 2024before the open | $1.61B | +3.1% | $0.49 | $0.49 | Release |
| Q2 FY2024ended Aug 3, 2024 | Aug 28, 2024before the open | $1.53B | -2.1% | $0.68 | $0.37 | Release |
| Q1 FY2024ended May 4, 2024 | Jun 4, 2024before the open | $1.38B | -0.9% | $0.38 | $0.38 | Release |
| Q4 FY2023ended Feb 3, 2024 | Feb 29, 2024before the open | $2.91B | +0.8% | $2.55 | $2.06 | Release |
| Q3 FY2023ended Oct 28, 2023 | Nov 16, 2023before the open | $1.56B | -2.4% | $0.52 | $0.48 | Release |
| Q2 FY2023ended Jul 29, 2023 | Aug 23, 2023before the open | $1.56B | -3.6% | $0.43 | $0.40 | Release |
| Q1 FY2023ended Apr 29, 2023 | May 18, 2023before the open | $1.40B | -3.7% | $0.35 | $0.33 | Release |
| Q4 FY2022ended Jan 28, 2023 | Feb 23, 2023before the open | $2.89B | -4.6% | $1.86 | $1.86 | Release |
| Q3 FY2022ended Oct 29, 2022 | Nov 16, 2022during market hours | $1.60B | -4.8% | $0.40 | $0.40 | Release |
| Q2 FY2022ended Jul 30, 2022 | Aug 17, 2022during market hours | $1.62B | – | $0.52 | – | Release |
| Q1 FY2022ended Apr 30, 2022 | May 18, 2022during market hours | $1.45B | – | $0.64 | $0.64 | Release |
| Q4 FY2021ended Jan 29, 2022 | Feb 23, 2022during market hours | $3.03B | – | $2.27 | $2.30 | Release |
| Q3 FY2021ended Oct 30, 2021 | Nov 17, 2021during market hours | $1.68B | – | $0.66 | $0.92 | Release |
| Q2 FY2021ended Jul 31, 2021 | Aug 18, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended May 1, 2021 | May 11, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Jan 30, 2021 | Feb 24, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Oct 31, 2020 | Nov 18, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2020ended Aug 1, 2020 | Aug 19, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Bath & Body Works's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net sales | Q3 FY2026 | -5% – -2.5% | – | New | Aug 26, 2026 |
| earnings per diluted shareGAAP | Q3 FY2026 | $0.05 – $0.10 | – | New | Aug 26, 2026 |
| adjusted earnings per diluted sharenon-GAAP | Q3 FY2026 | $0.07 – $0.12 | – | New | Aug 26, 2026 |
| net sales | FY2026 | -4% – -2.5% | -4.5% – -2.5% | Raised | Aug 26, 2026 |
| earnings per diluted shareGAAP | FY2026 | $3.13 – $3.33 | $3.00 – $3.25 | Raised | Aug 26, 2026 |
| adjusted earnings per diluted sharenon-GAAP | FY2026 | $2.60 – $2.80 | $2.40 – $2.65 | Raised | Aug 26, 2026 |
| free cash flownon-GAAP | FY2026 | $650.00M | $600.00M | Raised | Aug 26, 2026 |
| Forecasted Capital Expenditures | FY2026 | $270.00M | – | New | Mar 4, 2026 |
| Forecasted Net Cash Provided by Operating ActivitiesGAAP | FY2026 | $870.00M | – | New | Mar 4, 2026 |
Guidance vs results
The last range Bath & Body Works gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | EPS (GAAP) | $0.20 – $0.25 | $0.58 | Above range |
| Q2 FY2026 | Revenue growth | -5% – -3% | -2.26% | Above range |
| Q1 FY2026 | adjusted earnings per diluted share | $0.24 – $0.30 | $0.32 | Above range |
| Q1 FY2026 | EPS (GAAP) | $0.84 – $0.90 | $0.90 | Within range |
| Q1 FY2026 | Revenue growth | -6% – -4% | -3.23% | Above range |
| FY2025 | EPS (GAAP) | $2.83 | $3.15Σ4Q | Above range |
| Q4 FY2025 | EPS (GAAP) | $1.70 | $1.99 | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.37 – $0.45 | $0.37 | Within range |
| Q3 FY2025 | Revenue growth | +1% – +3% | -0.99% | Below range |
| Q2 FY2025 | EPS (GAAP) | $0.33 – $0.38 | $0.30 | Below range |
| Q1 FY2025 | EPS (GAAP) | $0.36 – $0.43 | $0.49 | Above range |
| Q1 FY2025 | Revenue growth | +1% – +3% | +2.89% | Within range |
| Q4 FY2024 | EPS (GAAP) | $1.94 – $2.07 | $2.09 | Above range |
| Q4 FY2024 | Revenue growth | -6.5% – -4.5% | -4.26% | Above range |
| Q3 FY2024 | EPS (GAAP) | $0.41 – $0.47 | $0.49 | Above range |
| Q2 FY2024 | EPS (GAAP) | $0.31 – $0.36 | $0.68 | Above range |
| Q1 FY2024 | EPS (GAAP) | $0.28 – $0.33 | $0.38 | Above range |
| Q1 FY2024 | Revenue growth | -4.5% – -2% | -0.86% | Above range |
| Q4 FY2023 | EPS (GAAP) | $1.70 – $1.90 | $2.55 | Above range |
| Q4 FY2023 | Revenue growth | -5% – -1% | +0.8% | Above range |
| Q3 FY2023 | EPS (GAAP) | $0.30 – $0.40 | $0.52 | Above range |
| Q3 FY2023 | Revenue growth | -4% – -2.5% | -2.38% | Above range |
| Q2 FY2023 | EPS (GAAP) | $0.27 – $0.32 | $0.43 | Above range |
| Q1 FY2023 | EPS (GAAP) | $0.17 – $0.27 | $0.35 | Above range |
| Q4 FY2022 | EPS (GAAP) | $1.45 – $1.65 | $1.86 | Above range |
| Q3 FY2022 | EPS (GAAP) | $0.10 – $0.20 | $0.40 | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.60 – $0.65 | $0.52 | Below range |
| Q1 FY2022 | EPS (GAAP) | $0.47 – $0.55 | $0.64 | Above range |
| Q4 FY2021 | EPS (GAAP) | $2.10 – $2.25 | $2.27 | Above range |
Guidance history
Every forecast Bath & Body Works put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 26, 2026 | adjusted earnings per diluted share | FY2026 | $2.60 – $2.80 | Raised |
| Aug 26, 2026 | adjusted earnings per diluted share | Q3 FY2026 | $0.07 – $0.12 | New |
| Aug 26, 2026 | earnings per diluted share | FY2026 | $3.13 – $3.33 | Raised |
| Aug 26, 2026 | earnings per diluted share | Q3 FY2026 | $0.05 – $0.10 | New |
| Aug 26, 2026 | free cash flow | FY2026 | $650.00M | Raised |
| Aug 26, 2026 | net sales | FY2026 | -4% – -2.5% | Raised |
| Aug 26, 2026 | net sales | Q3 FY2026 | -5% – -2.5% | New |
| May 27, 2026 | adjusted earnings per diluted share | FY2026 | $2.40 – $2.65 | Reaffirmed |
| May 27, 2026 | earnings per diluted share | FY2026 | $3.00 – $3.25 | Reaffirmed |
| May 27, 2026 | earnings per diluted share | Q2 FY2026 | $0.20 – $0.25 | New |
| May 27, 2026 | free cash flow | FY2026 | $600.00M | Reaffirmed |
| May 27, 2026 | net sales | FY2026 | -4.5% – -2.5% | Reaffirmed |
| May 27, 2026 | net sales | Q2 FY2026 | -5% – -3% | New |
| Mar 4, 2026 | Forecasted Capital Expenditures | FY2026 | $270.00M | New |
| Mar 4, 2026 | adjusted earnings per diluted share | FY2026 | $2.40 – $2.65 | New |
| Mar 4, 2026 | adjusted earnings per diluted share | Q1 FY2026 | $0.24 – $0.30 | New |
| Mar 4, 2026 | earnings per diluted share | FY2026 | $3.00 – $3.25 | New |
| Mar 4, 2026 | earnings per diluted share | Q1 FY2026 | $0.84 – $0.90 | New |
| Mar 4, 2026 | free cash flow | FY2026 | $600.00M | New |
| Mar 4, 2026 | Forecasted Net Cash Provided by Operating Activities | FY2026 | $870.00M | New |
| Mar 4, 2026 | net sales | FY2026 | -4.5% – -2.5% | New |
| Mar 4, 2026 | net sales | Q1 FY2026 | -6% – -4% | New |
| Nov 20, 2025 | Forecasted Capital Expenditures | FY2025 | $240.00M | New |
| Nov 20, 2025 | adjusted earnings per diluted share | FY2025 | $2.87 | New |
| Nov 20, 2025 | earnings per diluted share | FY2025 | $2.83 | New |
| Nov 20, 2025 | earnings per diluted share | Q4 FY2025 | $1.70 | New |
| Nov 20, 2025 | free cash flow | FY2025 | $650.00M | New |
| Nov 20, 2025 | Forecasted Net Cash Provided by Operating Activities | FY2025 | $890.00M | New |
| Aug 28, 2025 | adjusted earnings per diluted share | FY2025 | $3.35 – $3.60 | New |
| Aug 28, 2025 | earnings per diluted share | Q3 FY2025 | $0.37 – $0.45 | New |
| Aug 28, 2025 | earnings per diluted share | FY2025 | $3.28 – $3.53 | New |
| Aug 28, 2025 | free cash flow | FY2025 | $750.00M – $850.00M | Reaffirmed |
| Aug 28, 2025 | net sales | Q3 FY2025 | +1% – +3% | New |
| Aug 28, 2025 | net sales | FY2025 | +1.5% – +2.7% | Narrowed |
| May 29, 2025 | earnings per diluted share | Q2 FY2025 | $0.33 – $0.38 | New |
| May 29, 2025 | earnings per diluted share | FY2025 | $3.25 – $3.60 | Reaffirmed |
| May 29, 2025 | free cash flow | FY2025 | $750.00M – $850.00M | Reaffirmed |
| May 29, 2025 | net sales | FY2025 | +1% – +3% | Reaffirmed |
| May 19, 2025 | earnings per diluted share | FY2025 | $3.25 – $3.60 | Reaffirmed |
| May 19, 2025 | net sales | FY2025 | +1% – +3% | Reaffirmed |
| Feb 27, 2025 | Forecasted Capital Expenditures | FY2025 | $270.00M – $250.00M | New |
| Feb 27, 2025 | earnings per diluted share | FY2025 | $3.25 – $3.60 | New |
| Feb 27, 2025 | earnings per diluted share | Q1 FY2025 | $0.36 – $0.43 | New |
| Feb 27, 2025 | free cash flow | FY2025 | $750.00M – $850.00M | New |
| Feb 27, 2025 | Forecasted Net Cash Provided by Operating Activities | FY2025 | $1.02B – $1.10B | New |
| Feb 27, 2025 | net sales | Q1 FY2025 | +1% – +3% | New |
| Feb 27, 2025 | net sales | FY2025 | +1% – +3% | New |
| Nov 25, 2024 | adjusted earnings per diluted share | FY2024 | $3.15 – $3.28 | Raised |
| Nov 25, 2024 | earnings per diluted share | Q4 FY2024 | $1.94 – $2.07 | New |
| Nov 25, 2024 | earnings per diluted share | FY2024 | $3.46 – $3.59 | Raised |
| Nov 25, 2024 | net sales | Q4 FY2024 | -6.5% – -4.5% | New |
| Nov 25, 2024 | net sales | FY2024 | -2.5% – -1.7% | Raised |
| Aug 28, 2024 | adjusted earnings per diluted share | FY2024 | $3.06 – $3.26 | New |
| Aug 28, 2024 | earnings per diluted share | Q3 FY2024 | $0.41 – $0.47 | New |
| Aug 28, 2024 | earnings per diluted share | FY2024 | $3.37 – $3.57 | Raised |
| Aug 28, 2024 | net sales | FY2024 | -4% – -2% | New |
| Jun 4, 2024 | earnings per diluted share | FY2024 | $3.05 – $3.35 | New |
| Jun 4, 2024 | earnings per diluted share | Q2 FY2024 | $0.31 – $0.36 | New |
| Feb 29, 2024 | earnings per diluted share | FY2024 | $3.00 – $3.35 | New |
| Feb 29, 2024 | earnings per diluted share | Q1 FY2024 | $0.28 – $0.33 | New |
| Feb 29, 2024 | net sales | Q1 FY2024 | -4.5% – -2% | New |
| Nov 16, 2023 | adjusted earnings per diluted share | FY2023 | $2.90 – $3.10 | Raised |
| Nov 16, 2023 | earnings per diluted share | Q4 FY2023 | $1.70 – $1.90 | New |
| Nov 16, 2023 | earnings per diluted share | FY2023 | $2.99 – $3.19 | Raised |
| Nov 16, 2023 | net sales | FY2023 | -4% – -2.5% | Lowered |
| Nov 16, 2023 | net sales | Q4 FY2023 | -5% – -1% | New |
| Aug 23, 2023 | adjusted earnings per diluted share | FY2023 | $2.80 – $3.10 | Raised |
| Aug 23, 2023 | earnings per diluted share | Q3 FY2023 | $0.30 – $0.40 | New |
| Aug 23, 2023 | earnings per diluted share | FY2023 | $2.85 – $3.15 | Raised |
| Aug 23, 2023 | net sales | Q3 FY2023 | -4% – -2.5% | New |
| Aug 23, 2023 | net sales | FY2023 | -3.5% – -1.5% | New |
| May 18, 2023 | adjusted earnings per diluted share | FY2023 | $2.68 – $3.08 | New |
| May 18, 2023 | earnings per diluted share | Q2 FY2023 | $0.27 – $0.32 | New |
| May 18, 2023 | earnings per diluted share | FY2023 | $2.70 – $3.10 | Raised |
| Feb 23, 2023 | earnings from continuing operations per diluted share | Q1 FY2023 | $0.17 – $0.27 | New |
| Feb 23, 2023 | earnings from continuing operations per diluted share | FY2023 | $2.50 – $3.00 | New |
| Nov 16, 2022 | earnings from continuing operations per diluted share | Q4 FY2022 | $1.45 – $1.65 | New |
| Nov 16, 2022 | earnings from continuing operations per diluted share | FY2022 | $3.00 – $3.20 | Lowered |
| Aug 17, 2022 | earnings from continuing operations per diluted share | Q3 FY2022 | $0.10 – $0.20 | New |
| Aug 17, 2022 | earnings from continuing operations per diluted share | FY2022 | $2.70 – $3.00 | New |
| May 18, 2022 | earnings from continuing operations per diluted share | Q2 FY2022 | $0.60 – $0.65 | New |
| May 18, 2022 | earnings from continuing operations per diluted share | FY2022 | $3.80 – $4.15 | Lowered |
| Feb 23, 2022 | earnings per share from continuing operations | Q1 FY2022 | $0.47 – $0.55 | New |
| Feb 23, 2022 | earnings per share from continuing operations | FY2022 | $4.30 – $4.70 | New |
| Nov 17, 2021 | earnings per share | Q4 FY2021 | $2.10 – $2.25 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Bath & Body Works filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- News
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?